The locus of tumor necrosis factor-α action in lung inflammation

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 6, 1998, Pages 881-891

  Smith, Sherilyn ^b   Skerrett, Shawn J ^b   Chi, Emil Y ^b   Jonas, Mechthild ^b   Mohler, Kendall ^b   Wilson, Christopher B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C; BACTERIAL ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; C57BL MOUSE; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; MICROMONOSPORACEAE; MOUSE; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; PNEUMONIA; PROMOTER REGION; TRANSGENIC MOUSE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; APOLIPOPROTEINS C; IMMUNOGLOBULIN FC FRAGMENTS; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROMONOSPORACEAE; NEUTROPHILS; PNEUMONIA; PROMOTER REGIONS (GENETICS); RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032245882     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.6.3146     Document Type: Article

References (59)

1. Strieter, R., and S. Kunkel. 1994. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J. Invest. Med. 42:640-651.
2. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immmunol. 10:411-452.
3. Beutler, B., and G. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21:S423-S434.
4. Denis, M., Y. Cormier, M. Fourniet, J. Tardif, and M. Laviolette. 1991. Tumor necrosis factor plays an essential role in determining hypersensitivity pneumonitis in a mouse model. Am. J. Respir. Cell Mol. Biol. 5:477-483.
5. Denis, M., Y. Cormier, J. Tardif, E. Ghardirian, and M. Laviolette. 1991. Hypersensitivity pneumonitis: whole Micropolyspora faeni or antigens thereof stimulate the release of proinflammatory cytokines from macrophages. Am. J. Respir. Cell Mol. Biol. 5:198-203.
6. Laichalk, L., S. Kunkel, R. Strieter, J. Danforth, M. Bailie, and T. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64:5211-5218.
7. Gosselin, D., J. DeSanctis, M. Boule, E. Skamene, C. Matouk, and D. Radzioch. 1995. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63:3272-3278.
8. Kolls, J., L. Dinghua, S. Nelson, W. Summer, S. Greenberg, and B. Beutler. 1995. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171:570-575.
9. Buret, A., M. Dunkley, G. Pang, R. Clancy, and A. Cripps. 1994. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats: roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1alpha. Infect. Immun. 62:5335-5343.
10. Sonoda, F., K. Oishi, A. Iwagaki, and K. Matsumoto. 1997. Endogenous tumor necrosis factor (TNF)-α mediates neutrophil accumulation at the mid-phase of a murine model of Pseudomonas aeruginosa pneumonia. Microbiol. Immunol. 41:601-608.
11. Tang, W., E. Yi, D. Remick, A. Wittwer, S. Yin, M. Qi, and T. Ulich. 1995. Intratracheal injection of endotoxin and cytokines: IX. Contribution of CD11a/ICAM-1 to neutrophil emigration. Am. J. Physiol. 269:L653-L659.
12. Ulich, T., S. Yin, D. Remick, D. Russell, S. Eisenberg, and T. Kohno. 1993. Intratracheal administration of endotoxin and cytokines: IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am. J. Pathol. 142:1335-1338.
13. Ulich, T., E. Yi, S. Yin, C. Smith, and D. Remick. 1994. Intratracheal administration of endotoxin and cytokines: VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. Clin. Immunol. Immunopathol. 72 (1):137-140.
14. Kolls, J., S. Nelson, and W. Summer. 1993. Recombinant cytokines and pulmonary host defense. Am. J. Med. Sci. 306:330-335.
15. Jaffe, H., R. Buhl, and A. Mastrangeli. 1991. Organ-specific cytokine therapy: local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-γ to the human lung. J. Clin. Invest. 88:297-302.
16. Nelson, S., G. Bagby, and B. Bainton. 1989. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J. Infect. Dis. 159:189-194.
17. WienerKronish, J., K. Albertine, and M. Matthay. 1991. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Invest. 88:864-875.
18. Anderson, J., A. Knott, M. Wilson, R. Garrison, D. Sims, and M. Edwards. 1995. The effect of soluble tumour necrosis factor receptor-II on endotoxin-mediated hemodynamic instability. J. Surg. Res. 58:53-57.
19. Blanchard, D., J. Djeu, and T. Klein. 1988. Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J. Leukocyte Biol. 43:429-435.
20. Doyle, N., S. Bhagwan, B. Meek, G. Kutkoski, D. Steeber, T. Tedder, and C. Doerschuk. 1997. Neutrophil margination, sequestration, and emigration in the lungs of L-selectin-deficient mice. J. Clin. Invest. 99:526-533.
21. Evan, T., D. Moyes, A. Carpenter, R. Martin, H. Loetscher, W. Lesslauer, and J. Cohen. 1994. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis. J. Exp. Med. 180:2173-2179.
22. Garcia, I., M. Yoshitaka, K. Araki, R. Lucas, G. Grau, G. Milon, Y. Belkaid, C. Montixi, W. Lesslauer, and P. Vassalli. 1995. Transgenic mice expressing high levels of soluble TNFR1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25:2401-2407.
23. Jin, H., R. Yang, S. Marsters, S. Bunting, F. Wurm, S. Chamow, and A. Ashenzai. 1994. Protection against rat endotoxic shock by p55 tumour necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody. J. Infect. Dis. 170:1323-1326.
24. Katsunori, T., K. Tateda, T. Matsumoto, Y. Iizawa, M. Nakao, and K. Yamaguchi. 1997. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun. 65:257-260.
25. Kolls, J., K. Peppel, M. Silva, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91:215-219.
26. Lesslauer, W., H. Tabuchi, M. Brockhaus, E. Schlaeger, G. Gran, P. Piguet, P. Pointaire, P. Vassalli, and H. Loetscher. 1991. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur. J. Immunol. 21:2883-2886.
27. Mohler, K., D. Torrence, and C. Smith. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548-1561.
28. Moreland, L., G. Margolies, L. Heck, A. Saway, C. Blosch, R. Hanna, and W. Koopman. 1996. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis. J. Rheumatol. 23:1849-1855.
29. Nakano, Y., K. Onozuka, and Y. Terada. 1990. Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis. J. Immunol. 144:1935-1941.
30. Peppel, K., D. Crawford, and B. Beutler. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174:1483-1489.
31. Van Zee, K., L. Moldawer, H. Oldenburg, W. Thompson, S. Stackpole, W. Montegut, M. Rogy, C. Meschter, H. Gallati, C. Schiller, W. Richter, H. Loetscher, A. Ashenazi, S. Chamow, F. Wurm, S. Calvano, S. Lowry, and W. Lesslauer. 1996. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-Ig fusion protein, Ro 45-2081. J. Immunol. 156:2221-2230.
32. Skerrett, S., G. Bagby, R. Schmidt, and S. Nelson. 1997. Antibody-mediated depletion of tumor necrosis factor-α impairs pulmonary host defenses to Legionella pneumophila. J. Infect. Dis. 176:1019-1028.
33. Terlizzese, M., P. Simoni, and F. Antonetti. 1996. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-α and TNF-β. J. Interferon Cytokine Res. 16:1047-1053.
34. Rothe, J., W. Lesslauer, P. Lotscher, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bleuthmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
35. Pfeffer, K., T. Matsuyama, T. Kundig, A. Wakeman, K. Kishihara, K. Wiegmann, P. Ohashi, M. Kronke, and T. Mak. 1993. Mice deficient for the 55kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
36. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105.
37. Peschon, J., D. Dauphine, K. Stocking, M. Glaccum, C. Otten, C. Willis, K. Charrier, P. Morrissey, C. Ware, and K. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943-952.
38. Korfhagen, T., S. Glasser, and S. Wert. 1990. Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 87:6122-6126.
39. Hogan, B., R. Beddington, F. Constanini, and E. Lacy. 1994. Production of transgenic mice. In Manipulating the Mouse Embryo: A Laboratory Manual. Vol. 1. Cold Spring Harbor Laboratory Press, Plainview, NY. 217-248.
40. Ausubel, F., R. Brent, R. Kingston, D. Moore, J. Seidman, J. Smith, and K. Struhl. 1997. Current Protocols in Molecular Biology, Vol. 1. V. B. Chanda, editor. John Wiley & Sons, New York, 4.2.5-4.2.9.
41. Lewis, D., C. Yu, J. Meyer, K. Engligh, S. Kahn, and C. Wilson. 1991. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-γ production by neonatal T cells. J. Clin. Invest. 87:194-202.
42. Rennard, S., G. Basset, D. Lecossier, K. O'Donnell, P. Pinkston, P. Martin, and R. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J. Appl. Physiol. 60:532-538.
43. Martin, T., L. Altman, and O. Alvares. 1983. The effects of severe protein-calorie malnutrition on antibacterial defense mechanisms in the rat lung. Am. Rev Respir. Dis. 128:1013-1019.
44. Lehmann, V., M. Freudenberg, and C. Galanos. 1987. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine-treated mice. J. Exp. Med. 165:657-663.
45. Rothstein, J., and H. Schreiber. 1988. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. USA 85:607-611.
46. Glasser, S., T. Korfhagen, S. Wert, M. Bruno, K. McWilliams, D. Vorbroker, and J. Whitsett. 1991. Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice. Am. J. Physiol. 261:L349-L356.
47. Glasser, S., T. Korfhagen, S. Wert, and J. Whitsett. 1944. Transgenic models for study of pulmonary development and disease. Am. J. Physiol. (Lung Cell Mol. Physiol.) 267:L489-L497.
48. Frenette, P., and D. Wagner. 1996. Adhesion molecules: I. N. Engl. J. Med. 334:1526-1529.
49. Frenette, P., and D. Wagner. 1996. Adhesion molecules: II. Blood vessels and blood cells. N. Engl. J. Med. 335:43-45.
50. Kumasaka, T., W. Quinlan, N. Doyle, T. Condon, J. Sligh, F. Takei, A. Beaudet, C. Bennett, and C. Doershuk. 1996. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J. Clin. Invest. 97:2362-2369.
51. Aderka, D., H. Engelman, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors. J. Exp. Med. 175:323-329.
52. Tartaglia, L., M. Rothe, and Y. Hu. 1993. Tumor necrosis factor's cytotoxic activity is signalled by the p55 receptor. Cell 73:213-216.
53. Gascon, M., H. Porchet, J. Le Cotonnec, A. Ythier, D. Wallach, P. Piguet, and G. Grau. 1992. Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice. Drug Metab. Dispos. 20:592-595.
54. Wooley, P., J. Dutcher, M. Widmer, and S. Gillis. 1993. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on collagen-induced arthritis in mice. J. Immunol. 151:6602-6607.
55. Van Zee, K., T. Kohno, and E. Fischer. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89:4845-4849.
56. Suffredini, A., D. Reda, S. Banks, M. Tropea, J. Agosti, and R. Miller. 1995. Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J. Immunol. 155: 5038-5045.
57. Qin, L., W. Quinlan, N. Doyle, L. Graham, J. Sligh, T. Fumio, A. Beaudet, and C. Doerschuk. 1996. the roles of CD11/CD18 and ICAM-1 in acute Pseudomonas aeruginosa-induced pneumonia in mice. J. Immunol. 157: 5016-5021.
58. Takashima, K., K. Tateda, T. Matsumoto, Y. Iizawa, M. Nakao, and K. Yamaguchi. 1997. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun. 65:257-260.
59. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.